Our Technology

Illumina is leading the way in the genetics community with technologies that translate the genome (DNA) into something people can begin to read and interpret. Illumina's technology is found in top research institutions around the world, and is now available to you through the Illumina Individual Genome Sequencing (IGS) service. This service provides patients and doctors with genetic information that, together with essential medical information, can be leveraged to make informed decisions related to your health and well being.

Why does technology matter?

Every day scientists around the world rely on Illumina's technology to power their research and advance their understanding of genetics. The technology they use is critical to their progress. It must be reliable, accurate, comprehensive, and fast.

They choose Illumina as a partner because our technology is proven and they can trust the data. Scientists know that with Illumina technology, they can find answers faster. In fact, researchers around the world have published groundbreaking studies on hundreds of diseases and genetic factors using Illumina technology. Illumina is enabling deeper insights into the genome while delivering quality information accurately and quickly, turning studies once dreamed of into a reality.

First Name: *
Last Name: *
Country: *
Email: *
Phone:
Reason for Inquiry: *
Comments:

SUBMIT

Illumina

Please note:
Individual Genome Sequencing will be performed in Illumina's CLIA (Clinical Laboratory Improvements Amendment)-certified and CAP (College of American Pathologists)-accredited Clinical Services Laboratory's, under a valid and unexpired California Clinical Laboratory License. The Individual Genome Sequence information is generated by licensed personnel using an analytically validated process. Consistent with Lab Developed Tests, it has not been cleared or approved by the U.S. Food and Drug Administration.

This genome sequence information can be analyzed to potentially aid your doctor in the evaluation of a broad range of health conditions or physiological traits. You will not receive medical results, or a diagnosis, or a recommendation for treatment from Illumina. Any results arising from the analysis of your genome sequence information that might be deemed medically actionable should be confirmed using alternative testing. If you have any questions or concerns about what you learn through your genome sequence information, you should contact your doctor or a genetic counselor.

Currently Illumina does not accept orders for individual genome sequencing services from the following states: Florida, New York, and Rhode Island.